Ancrod for the Treatment of Acute Ischemic Brain Infarction
Stroke 25:1755-1759, Sherman,D.G.,et al, 1994
Prospective Study of Endogenous Tissue Plasminogen Activator and Risk of Stroke
Lancet 343:940-943, Ridker,P.M.,et al, 1994
Amyotrophic Lateral Sclerosis Patient Antibodies Label CA2+Channel a1 Subunit
Ann Neurol 35:164-171, 1311994., Fumiharu,K.,et al, 1994
Familial Autoimmune Myasthenia Gravis
Neurol 44:551-554, Bergoffen,J.,et al, 1994
Evidence for Long-Term Survival and Function of Dopaminergic Grafts in Progressive Parkinson's Disease
Ann Neurol 35:172-180, Lindvall,O.,et al, 1994
Neurovascular Manifestations of Heritable Connective Tissue Disorders:A Review
Stroke 25:889-903, Schievink,W.I.,et al, 1994
Coexistence of Fibromuscular Dysplasia and Cystic Medial Necrosis in a Patient with Marfans Syndrome and Bilateral Carotid Artery Dissections
Stroke 25:2492-2496, Schievink, W.I.,et al, 1994
The Polymerase Chain Reaction:Application to Nervous System Disease
Ann Neurol 34:513-523, Darnell,R.B., 1993
Thrombolytic Therapy in Acute Ischemic Stroke
Stroke 24:1439-1446, Overgaard,K.,et al, 1993
Individual Risk Assessment for Intracranial Haemorrhage During Thrombolytic Therapy
Lancet 342:1523-1528, Simoons,M.L.,et al, 1993
Expression of Thyrotropin-Receptor mRNA in Healthy and Graves'Disease Retro-Orbital Tissue
Lancet 342:337-338, 3181993., Feliciello,A.,et al, 1993
Faithful Fashion:Survival Status of the Brain Transplant Cure for Parkinsonism
Neurol 43:644-649, Landau,W.M., 1993
Autoantibodies to a 128-kd Synaptic Protein in Three Women with the Stiff-Man Syndrome & Breast Cancer
NEJM 328:546-551, Folli,F.,et al, 1993
Antineuronal (anti-Ri) Antibodies in a Pt with Steroid-Responsive Opsoclonus-Myoclonus
Neurol 43:207-211, Dropcho,E.J.,et al, 1993
Myocardial Infarction, Thrombolytic Therapy, and Stroke, A Community-Based Study
Stroke 24:587-590, Longstreth,W.T.,et al, 1993
Intracerebral Hemorrhage After Fibrinolytic Therapy for Acute Myocardial Infarction
C. R. , Stroke 24:554-557, 5233., Wijdicks,E.F.M.&Jack,Jr, 1993
Low Back Pain Associated with Anistreplase
BMJ 306:896, Lear,J.&Rajapakse,R., 1993
Pilot Randomized Trial of Tissue Plasminogen Activator in Acute Ischemic Stroke
Stroke 24:1000-1004, Haley,E.C.,et al, 1993
Neurosurgical Horizons in Parkinson's Disease
Neurol 43:1-7, Goetz,C.G.,et al, 1993
Evolving Toward Effective Therapy for Acute Ischemic Stroke
JAMA 270:360-364, Fisher,M.&Bogousslavsky,J., 1993
Functional Integration of Cortical Grafts Placed in Brain Infarcts of Rats
Ann Neurol 34:362-368, Grabowski,M.,et al, 1993
Transplants for Stroke Patients
Ann Neurol 34:322-323, Sharp,F.R., 1993
Association of Serum Antibodies to Heart-Shock Protein 65 with Carotid Atherosclerosis
Lancet 341:255-259, 2781993., Xu,Q.,et al, 1993
Stroke Complic Acute MI, A Meta-Analysis of Risk Modific by Antigoac & Thrombolytic Therapy
Arch Int Med 152:2020-2024, Viatkus,P.T.,et al, 1992
Thrombolysis in Acute Ischemic Stroke:Does it Work
Stroke 23:1826-1839, Wardlaw,J.M.&Warlow,C.P., 1992
Neurologic Manifestations of Progressive Systemic Sclerosis
Arch Neurol 49:1292-1295, Averbuch-Heller,L.,et al, 1992
Recurrent Transverse Myelitis, Myasthenia Gravis, and Autoantibodies
Ann Neurol 32:407-409, Lindsey,J.W.,et al, 1992
Transplantation of Fetal Dopamine Neurons in Parkinson's Disease:One-year Clin Obser in 2 Pts with Putaminal Implants
Ann Neurol 31:155-165, Lindvall,O.,et al, 1992
Transplantation of Fetal Dopamine Neurons in Parkinson's Disease:PET Studies in 2 Pts with Putaminal Implants
Ann Neurol 31:166-173, Sawle,G.V.,et al, 1992
A Prospective Study of Cognitive Funct Following Low-Dose Cranial Radiation for Bone Marrow Trnsplant
Pediatrics 90:447-450, Kramer,J.H.,et al, 1992
Early Computed Tomographic Findings for Thrombolytic Therapy in Patients with Acute Brain Embolism
Stroke 23:20-23, Okada,Y.,et al, 1992
The Risk of Stroke in Patients with Acute Myocardial Infarction after Thrombolytic and Antithrombotic Treatment
NEJM 327:1-6, Maggioni,A.P.,et al, 1992
Intrinsic Spinal Cord Haemorrhage Due to Streptokinase Treatment for Myocardial Infarction
JNNP 55:740, Cruickshank,G.S.,et al, 1992
Urgent Therapy for Stroke Part II, Pilot Study of Tissue Plasminogen Activator Administered 91-180 Minutes from Onset
Stroke 23:641-645, Haley,E.C.,et al, 1992
Urgent Therapy for Stroke Part I, Pilot Study of Tissue Plasminogen Activator Administered within 90 Minutes
Stroke 23:632-640, Brott,T.G.,et al, 1992
Intravenous Recombinant Tissue Plasminogen Activator in Acute Carotid Artery Territory Stroke
Neurol 42:976-982, Mori,E.,et al, 1992
Safety & Efficacy of Intravenous Tissue Plasminogen Activator & Heparin in Acute Middle Cerebral Artery Stroke
Stroke 23:646-652, vonKummer,R.&Hacke,W., 1992
Intracranial Hemorrhage After Coronoary Thrombolysis with Tissue Plsminogen Activator
Am J Med 92:384-390, Kase,C.S.,et al, 1992
Recombinant Tissue Plasminogen Activator in Acute Thrombotic and Embolic Stroke
Ann Neurol 32:78-86, delZoppo,G.J.,et al, 1992
A Patient with Primary Biliary Cirrhosis and Multiple Sclerosis
Am J Med 92:433-436, Pontecorvo,M.J.,et al, 1992
Longitudinal Neurophysiologic Studies in Pt with Metachromatic Leukodystrophy Following Bone Marrow Trnspl
Arch Neurol 49:1088-1092, Dhuna,A.,et al, 1992
Unilateral Transpl of Human Fetal Mesencephalic Tissue Into the Caudate Nucleus of Pts with Parkinson's
NEJM 327:1541-1548, Spencer,D.D.,et al, 1992
Survival of Implanted Fetal Dopamine Cells & Neuro Improvement 12 to 46 Months after Transpl for Parkinson's
NEJM 327:1549-1555, 15891992., Freed,C.R.,et al, 1992
Bilateral Fetal Mesencephalic Grafting in Two Patients with Parkinsonism Induced by MPTP
NEJM 327:1556-1563, 15891992., Widner,H.,et al, 1992
The Use of Fetal Tissue in Research on Parkinson's Disease
NEJM 327:1591-1592, Kassirer,J.P.&Angell,M., 1992
Are There Really Alternatives to the Use of Fetal Tissue from Elective Abortions in Transplant Research?
NEJM 327:1592-1595, Garry,D.J.,et al, 1992
Amphotericin B-Associated Leukoencephalopathy
Neurol 42:2005-2010, Walker,R.W.&Rosenblum,M.K., 1992
Serum Antibodies to L-Type Calcium Channels in Patients with Amyotrophic Lateral Sclerosis
NEJM 327:1721-1728, 17521992., Smith,R.G.,et al, 1992
Tissue Plasminogen Activator Plus Glutamate Antagonist Improves Outcome after Embolic Stroke
Arch Neurol 48:1235-1238, Zivin,J.A.&Mazzarella,V., 1991
Thyroid-Associated Eye Disease:Clinical Management
Lancet 338:29-32, Fells,P., 1991